Tagged With Regeneron

A billionaire pharma exec close to Andrew Cuomo also got priority access to early COVID-19 tests, report says

Scammers set up fake websites posing as COVID-19 treatments to trick people into sharing personal information, US officials warn

The experimental coronavirus treatment Trump received just got emergency authorization from the FDA

27 biotech execs who've sold the most stock

27 pharma execs involved in the hunt for COVID-19 vaccines and treatments have raked in more than $1 billion by selling stock this year. Here's who's cashed in the most.

Regeneron CEO says Trump's experience with the company's COVID-19 drug is the 'weakest evidence you can get' of whether it works

More patients want to join antibody drug trials after Trump's coronavirus treatment — though we don't know yet if it actually helps COVID-19

Trump tells Rush Limbaugh he 'might not have recovered' from COVID-19 without Regeneron antibody cocktail

One of Trump's COVID-19 treatments was developed using tissue that originally came from an abortion. He's tried to ban this kind of research.

Trump just praised one of the experimental coronavirus treatments he got and said FDA should approve it

'That makes no sense': Doctors say Trump is either getting overtreated for the coronavirus, which could be risky, or is more seriously ill than we know

Regeneron jumps 10% as Trump gets the drugmaker's antibody treatment while hospitalized

What to know about Trump's coronavirus treatment regimen

Trump's doctors are targeting a 'sweet spot' in fighting COVID-19 by using experimental treatments early, but physicians caution the data is limited

Trump got Regeneron's experimental antibody drug for his coronavirus symptoms. Here's what you need to know about the treatment.

Regeneron widens its lead as the S&P 500's top performer after saying key COVID-19 drug may be available in the fall

Pharma giants Sanofi and Regeneron are now testing out an arthritis drug to treat the coronavirus, starting in New York

The decade's best stocks ranged from streaming giants to freight companies. Here are the 11 best performing equities of the 2010s.

The FDA just approved a new treatment for a common form of skin cancer

Regeneron's CEO has been outspoken about drug price hikes, but one of his company’s drugs just got more expensive